Drug manufacturer consulting
Served as lead consulting expert for a major drug manufacturer throughout a multiyear government investigation spanning several products and allegations, including that certain alleged price concessions were not factored into the calculation of ASP, causing the ASP and corresponding Medicare reimbursements to be overstated. Provided consulting expertise on liability, causation, and damages, and participated in settlement discussions with the government.